Apriori Bio Partners with Francis Crick Institute to Advance Variant-Resilient Vaccine Research
Apriori Bio has partnered with the Francis Crick Institute to leverage AI-driven insights and the Crick’s Legacy Study for developing variant-resilient vaccines against current and emerging viral threats.
Flagship Pioneering | 14/08/2025 | By Mrinmoy Dey
Flagship Pioneering and Quotient Therapeutics Signs Deal with Pfizer
Pioneering Medicines, Flagship’s in-house drug discovery and development unit, is responsible for leading the strategic partnership with Pfizer, including driving the exploration process to rapidly surface potential drug development programs built on Flagship’s diverse bioplatforms and modalities.
Flagship Pioneering | 29/08/2024 | By Aishwarya | 225
Flagship Pioneering and Metaphore Enter into Research Collaboration with Novo Nordisk
Metaphore Biotechnologies, in partnership with Flagship Pioneering, has inked a research collaboration with Novo Nordisk to develop up to two next-generation therapeutics for obesity management.
Flagship Pioneering | 10/05/2024 | By Aishwarya | 454
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy